The Danish Company Behind Ozempic
Feb 02, 2024•31 min•Ep 124•Transcript available on Metacast Episode description
The market value of Novo Nordisk, the Danish company that makes the weight loss drugs Wegovy and Ozempic, hit $500 billion this past week—a rare achievement for a European firm. Novo Nordisk is owned by a non-profit foundation, which gives the company an unusual corporate structure. Adam and Cameron discuss.
Learn more about your ad choices. Visit megaphone.fm/adchoices
